Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2015-09-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于筹划重大事项的停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company about the progress of a trading suspension related to a major matter, specifically the planning of a non-public stock issuance. It mentions the stock has been suspended and will continue to be suspended, with periodic progress updates promised. The content focuses on capital raising activities and stock trading suspension, not on financial results, management changes, or legal proceedings. The document length is short (546 characters), and it is an announcement about ongoing capital-related matters. Therefore, it fits best under Capital/Financing Update (CAP).
2015-09-23 Chinese
关于高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a senior management member (vice president) of the company. It includes no financial data, no report references, and is focused solely on management change. The document length is only 404 characters, indicating it is a brief announcement. Therefore, it fits the category of Board/Management Information (MANG).
2015-09-21 Chinese
关于筹划重大事项的停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the suspension of trading of the company's stock due to planning a major matter related to a non-public stock issuance. It mentions the stock code, the suspension date, and that progress updates will be provided every five trading days. There is no detailed financial data, no full report, and the document is only 499 characters long. It is clearly an update on a capital raising or financing activity (non-public stock issuance) and the trading suspension related to it. According to the definitions, this fits best under Capital/Financing Update (CAP).
2015-09-16 Chinese
关于筹划重大事项的停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the suspension of trading of the company's stock due to the planning of a major matter, specifically a non-public issuance of shares. It mentions the stock code, the suspension date, and the ongoing progress updates every five trading days. There is no detailed financial data, report, or presentation included. The document is an update on capital raising activities and stock suspension related to financing. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear mention of non-public issuance and trading suspension related to capital matters.
2015-09-09 Chinese
关于筹划重大事项的停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company about the suspension of its stock trading due to planning a major matter, specifically a non-public issuance of shares. It mentions the stock suspension, ongoing progress updates every five trading days, and an expected resumption date. This is an update on a capital/financing activity (non-public share issuance) and the stock suspension related to it. The document is short (497 characters) and is an announcement of progress rather than a detailed report or financial statement. Therefore, it fits best under Capital/Financing Update (CAP).
2015-08-31 Chinese
关于筹划重大事项的停牌进展公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading of the company's stock due to ongoing planning of a major matter. It references previous announcements about the suspension and states that updates will be provided every five trading days. The document does not contain financial statements, detailed financial data, or comprehensive report content. It is an update on a regulatory or corporate action related to stock trading suspension, which fits best under general regulatory announcements. Given the short length (506 characters) and the nature of the content, it is not a full report but a regulatory filing announcement.
2015-08-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.